Alpha-melanocyte-stimulating hormone attenuates behavioral effects of corticotropin-releasing factor in isolated guinea pig pups

Developmental Psychobiology

Volumn 51, Issue 5, 2009, Pages 399-407

  Schiml Webb, Patricia A ^a   Miller, Emily ^a   Deak, Terrence ^b   Hennessy, Michael B ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

^b BINGHAMTON UNIVERSITY   (United States)

Author keywords

Alpha melanocyte stimulating hormone; Corticotropin releasing hormone; Guinea pig; Maternal separation; Proinflammatory cytokines; Sickness behavior

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN RELEASING FACTOR;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANTIINFLAMMATORY ACTIVITY; ARTICLE; BEHAVIOR; FEMALE; GUINEA PIG; HORMONE ACTION; MALE; NONHUMAN; SOCIAL ISOLATION;

ALPHA-MSH; ANIMALS; ANIMALS, NEWBORN; ATROPINE; BEHAVIOR, ANIMAL; BRAIN; CORTICOTROPIN-RELEASING HORMONE; GUINEA PIGS; ILLNESS BEHAVIOR; INJECTIONS, INTRAMUSCULAR; SOCIAL ISOLATION; STEREOTAXIC TECHNIQUES; VOCALIZATION, ANIMAL;

CAVIA;

EID: 70349406235     PISSN: 00121630     EISSN: 10982302     Source Type: Journal    
DOI: 10.1002/dev.20379     Document Type: Article

References (59)

1. Aguilera, G., Flores, M., Carvallo, P., Harwood, J. P., Millan, M., & Catt, K. J. (1990). Receptors for corticotropin-releasing factor. In: E. B. DeSouza & C. B. Nemeroff (Eds.), Corticotropin-releasing factor: Basic and clinical studies of a neuropeptide (pp. 153-174). Boca Raton, FL: CRC Press, Inc.
2. Ayesta, F. J., & Nikolarakis, K. E. (1989). Peripheral but not intracerebroventricular corticotropin-releasing hormone (CRH) produces antinociception which is not opiate mediated. Brain Research, 503, 214-219.
3. Baker, C., Richards, L. J., Dayan, C. M., & Jessop, D. S. (2003). Corticotropin-releasing hormone immunoreactivity in human T and B cells and macrophages: Colocalization with arginine vasopressin. Journal of Neuroendocrinology, 15, 1070-1074.
4. Becker, L. A., & Hennessy, M. B. (1993). Further characterization of the behavioral effects of peripherally administered corticotropin-releasing factor in guinea pigs. Pharmacology, Biochemistry, and Behavior, 44, 925-930.
5. Berryman, J. C. (1976). Guinea pig vocalizations: Their structure, causation, and function. Zeitschrift fur Tierpsychologie, 41, 80-106.
6. Blalock, J. E., & Smith, E. M. (2007). Conceptual development of the immune system as a sixth sense. Brain, Behavior, and Immunity, 21, 23-33.
7. Britton, D. R., Koob, G. F., Rivier, J., & Vale, W. (1982). Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sciences, 31, 363-367.
8. Bruhn, G., Flores, M., Carvallo, P., Harwood, J. P., Millan, M., & Catt, K. J. (1987). Corticotropin-releasing factor in the dog adrenal medulla is secreted in response to hemorrhage. Endocrinology, 120, 25-33.
9. Catania, A., & Lipton, J. M. (1993). α-Melanocyte stimulating hormone in the modulation of host reactions. Endocrine Reviews, 14, 564-576.
10. Chowdrey, H. S., Lightman, S. L., Harbuz, M. S., Larsen, P. J., & Jessop, D. S. (1984). Contents of corticotropin-releasing hormone and arginine vasopressin immunoreactivity in the spleen and thymus during a chronic inflammatory stress. Journal of Neuroimmunology, 53, 17-21.
11. Crofford, L. J., Sano, H., Karalis, K., Webster, E. L., Goldmuntz, E. A., Chrousos, G. P., & Wilder, R. L. (1992). Local secretion corticotropin-releasing hormone in the joints of Lewis rats with inflammatory arthritis. Journal of Clinical Investigation, 90, 2555-2564.
12. Dufau, M. L., Tinajero, J. C., & Fabbri, A. (1993). Corticotropin-releasing factor: An antireproductive hormone of the testis. The FASEB Journal, 7, 299-307.
13. Eaves, M., Thatcher-Britton, K., Rivier, J., Vale, W., & Koob, G. F. (1985). Effects of corticotropin releasing factor on locomotor activity in hypophysectomized rats. Peptides, 6, 923-926.
14. Gonzalez, M. I., Vaziri, S., & Wilson, C. A. (1996). Behavioral effects of alpha-MSH and MCH after central administration in the female rat. Peptides, 17, 171-177.
15. Hagen, P. M., Poole, S., & Bristow, A. F. (1993). Corticotropin-releasing factor as a mediator of the acute-phase response in rats, mice, and rabbits. Journal of Endocrinology, 136, 207-216.
16. Hargreaves, K. M., Mueller, G. P., Dubner, R., Goldstein, D., & Dionne, R. A. (1987). Corticotropin-releasing factor (CRF) produces analgesia in humans and rats. Brain Research, 422, 154-157.
17. Harper, L. V. (1976). Behavior. In: J. V.Wagner & P. J. Manning (Eds.), The biology of the guinea-pig (pp. 31-51.). New York: Academic Press.
18. Hart, B. L. (1988). Biological basis of the behavior of sick animals. Neurobiological and Biobehavioral Reviews, 12, 123-137.
19. Hennessy, M. B., & Morris, A. (2005). Passive responses of young guinea pigs during exposure to a novel environment: Influences of social partners and age. Developmental Psychobiology, 46, 86-96.
20. Hennessy, M. B., Becker, L. A., & O'Neil, D. R. (1991). Peripherally administered CRH suppresses the vocalizations of isolated guinea pig pups. Physiology & Behavior, 50, 17-22.
21. Hennessy, M. B., O'Neil, D. R., Becker, L. A., Jenkins, R., Williams, M. T., & Davis, H. N. (1992). Effects of centrally administered corticotropin-releasing factors (CRF) and α-helical CRH on the vocalizations of isolated guinea pig pups. Pharmacology, Biochemistry, and Behavior, 43, 37-43.
22. Hennessy, M. B., Long, S. J., Nigh, C. K., Williams, M. T., & Nolan, D. J. (1995). Effects of peripherally administered corticotropin-releasing factor (CRF) and a CRF antagonist: Does peripheral CRF activity mediate behavior of guinea pig pups during isolation? Behavioral Neuroscience, 109, 1137-1145.
23. Hennessy, M. B., Deak, T., Schiml-Webb, P. A., Wilson, S. E., Greenlee, T. M., & McCall, E. (2004). Responses of guinea pig pups during isolation in a novel environment may represent stress-induced sickness behaviors. Physiology and Behavior, 81, 5-13.
24. Hennessy, M. B., Schiml-Webb, P. A., Miller, E. E., Maken, D. S., Bullinger, K. L., & Deak, T. (2007). Anti-inflammatory agents attenuate the passive responses of guinea pigs: Evidence for stress-induced sickness behavior during separation. Psychoneuroendocrinology, 32, 508-515.
25. Hennessy, M. B., Deak, T., Schiml-Webb, P. A., & Barnum, C. J. (2007). Immunological influences on behavioral and endocrine responses during early development. In: M. T Czerbska (Ed.), Psychoneuroendocrinology research trends (pp. 293-319). Hauppauge, NY: Nova Scientific Publishers.
26. Kalin, N. H., Shelton, S. E., Kraemer, G. W., & McKinney, W. T. (1983a). Corticotropin-releasing factor administered intraventricularly to rhesus monkeys. Peptides, 4, 217-220.
27. Kalin, N. H., Shelton, S. E., Kraemer, G. W., & McKinney, W. T. (1983b). Associated endocrine, physiological, and behavioral changes in rhesus monkeys after intravenous corticotropin-releasing factor administration. Peptides, 4, 211-215.
28. Kandasamy, S. B., & Williams, B. A. (1984). Hypothermic and antipyretic effects of ACTH (1-24) and alpha-melanotropin in guinea-pigs. Neuropharmacology, 23, 49-53.
29. Karalis, K., Sano, H., Redwine, J., Listwak, S.,Wilder, R. L., & Chrousos, G. P. (1991). Autocrine or paracrine inflammatory actions of corticotropin-releasing hormone in vivo. Science, 254, 421-423.
30. Kokare, D. M., Chopde, C. T., & Subhedar, N. K. (2006). Participation of alpha-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology, 51, 536-545.
31. Koob, G. F., Heinrichs, S. C., Pich, E. M., Menzaghi, F., Baldwin, H., Miczek, K., & Britton, K. T. (1993). The role of corticotropin-releasing factor in behavioural responses to stress. Ciba Foundation Symposium, 172, 277-289.
32. Korosi, A., & Baram, T. Z. (2008). The central corticotropin releasing factor system during development and adulthood. European Journal of Pharmacology, 583, 204-214.
33. Leu, S. J., & Singh, V. K. (1992). Stimulation of interleukin-6 production by corticotropin-releasing factor. Cellular Immunology, 143, 220-227.
34. Lipton, J. M., & Catania, A. (1997). Anti-inflammatory actions of the neuroimmunomodulator a-MSH. Immunology Today, 18, 140-143.
35. Luparello, T. J., (1967). Stereotaxic atlas of the forebrain of the guinea pig. Basel, Switzerland: S. Karger AG.
36. Maier, S. F., & Watkins, L. R. (1998). Cytokines for psychologists: Implications of bi-directional immune-to-brain communication for understanding behavior, mood, and cognition. Psychological Reviews, 105, 83-107.
37. Martins, J. M., Kastin, A. J., & Banks, W. A. (1996). Unidirectional specific and modulated brain to blood transport of corticotropin-releasing hormone. Neuroendocrinology, 63, 338-348.
38. Mastorakos, C., Scopa, C. D., Friedman, T. C., Malachrinou, M., Merino, M. J., & Chrousos, G. P. (1994). Presence of immunoreactive corticotropin-releasing hormone (CRH) in thyroid lesions. American Journal of Pathology, 145, 1159-1167.
39. Mastorakos, G., Scopa, C. D., Kao, L. C., Kattis, D., Phenekos, C., Rabin, D., & Chrousos, G. P. (1996). Presence of immunoreactive corticotropin-releasing hormone in human endometrium. Journal of Clinical Endocrinological Metabolism, 81, 1046-1050.
40. McInturf, S. M., & Hennessy, M. B. (1996). Peripheral administration of corticotropin-releasing factors antagonists increases the vocalizing and locomotor activity of isolated guinea pig pups. Physiology and Behavior, 60, 707-710.
41. McMinn, J. E., Wilkinson, C. W., Havel, P. J., Woods, S. C., & Schwartz, M. W. (2000). Effect of intracerebroventricular alpha-MSH on food intake, adiposity, c-Fos induction, and neuropeptide expression. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 279, R695-R703.
42. Owens, M. J., & Nemeroff, C. B. (1991). Physiology and pharmacology of corticotropin-releasing factor. Pharmacological Reviews, 43, 425-473.
43. Panksepp, J., & Abbott, B. B. (1990). Modulation of separation distress by alpha-MSH. Peptides, 11, 647-653.
44. Perkeybile, A. M., Schiml-Webb, P. A., O'Brien, E., Deak, T., & Hennessy, M. B. (in press). Anti-inflammatory influences on behavioral, but not cortisol, responses during maternal separation. Psychoneuroendocrinology.
45. Rao, T. L., Kokare, D. M., Sarkar, S., Khisti, R. T., Chopde, C. T., & Subhedar, N. (2003). GABAergic agents prevent alpha-melanocyte stimulating hormone induced anxiety and anorexia in rats. Pharmacology, Biochemistry, and Behavior, 76, 417-423.
46. Rivier, C., Brownstein, M., Speiss, J., Rivier, J., & Vale, W. (1982). In vivo corticotropin-releasing factor-induced secretion of adrenocorticotropin, β-endorphin and corticosterone. Endocrinology, 110, 272-278.
47. Sapolsky, R. M., Romero, L. M., & Munck, A. L. (2000). How do glucocorticoids influence stress responses? Integrating permissive, suppressive, and preparative actions. Endocrine Reviews, 21, 55-89.
48. Saunders, P. R., Maillot, C., Million, M., & Tache', Y. (2002). Peripheral corticotropin-releasing factor induces diarrhea in rats: Role of CRF1 receptor in fecal watery excretion. European Journal of Pharmacology, 435, 231-235.
49. Schiml-Webb, P. A., Deak, T., Greenlee, T. M., Maken, D., & Hennessy, M. B. (2006). Alpha-melanocyte stimulating hormone reduces putative stress-induced sickness behaviors in isolated guinea pig pups. Behavioral Brain Research, 168, 326-330.
50. Singh, V. K., & Leu, S. J. (1990). Enhancing effect of corticotropin-releasing neurohormone on the production of interleukin-1 and interleukin-2. Neuroscience Letters, 120, 151-154.
51. Singh, L. K., Pang, X., Alexacos, N., Letourneau, R., & Theoharides, T. C. (1999). Acute immobilization stress triggers skin mast cell degranulation via corticotropin releasing hormone, neurotensin, and substance, P: A link to neurogenic skin disorders. Brain, Behavior, and Immunology, 13, 225-239.
52. Swanson, L. W., Sawchenko, P. E., Rivier, J., & Vale, W. W. (1983). Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: An immunohistochemical study. Neuroendocrinology, 36, 165-186.
53. Tsigos, C., & Chrousos, G. P. (2002). Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. Journal of Psychosomatic Research, 53, 865-871.
54. Tsukamoto, K., Yakade, Y., Mantyh, C., Ludwin, K., Pappas, T. N., & Takahashi, T. (2006). Peripherally administered CRF stimulates colonic motility via central CRF receptors and vagal pathways in conscious rats. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology, 290, R1537-R1541.
55. Veldhuis, H. D., & De Wied, D. (1984). Differential behavioral actions of corticotropin-releasing factor (CRF). Pharmacology, Biochemistry, and Behavior, 21, 707-713.
56. Venihaki, M., Zhao, J., & Karalis, K. P. (2003). Corticotropin-releasing hormone deficiency results in impaired splenocyte response to lipopolysaccharide. Journal of Neuroimmunology, 141, 3-9.
57. Wadhwa, P. D., Garite, T. J., Porto, M., Glynn, L., Chicz-DeMet, A., Dunkel-Schetter, C., & Sandman, C. A. (2004). Placental corticotropin-releasing hormone (CRH), spontaneous preterm birth, and fetal growth restriction: A prospective investigation. American Journal of Obstetrics and Gynecology, 191, 1063-1069.
58. Webster, E. L., Lewis, D. B., Torpy, D. J., Zachman, E. K., Rice, K. C., & Chrousos, G. P. (1996). In vivo and in vitro characterization of antalarmin, a nonpeptide corticotropin-releasing hormone (CRH) receptor antagonist: Suppression of pituitary ACTH release and peripheral inflammation. Endocrinology, 137, 5747-5750.
59. Zybtek, B., & Slominski, A. T. (2007). CRH mediates inflammation induced by lipopolysaccharide in human adult epidermal keratinocytes. Journal of Investigative Dermatology, 127, 730-732.